Richard Gebhardt – Trademark Portfolio
Entity Type: 01
Richard Gebhardt holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 25 (Clothing) across 5 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include TURCHAI, TURMACHA, TURMOCHA, and TURPUMPKIN. The owner is based in Carmel, CA.
37125 Palo Colorado Road
Carmel, CA 93923
Showing of trademarks Trademarks
Trademark Classifications
Richard Gebhardt's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademarks does Richard Gebhardt have?
Richard Gebhardt has 15 U.S. trademarks filed with the USPTO. Of these, 4 registered, 9 abandoned, 2 cancelled.
What trademark classes does Richard Gebhardt file in?
Richard Gebhardt files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 16 (Paper Goods), Class 32 (Light Beverages), Class 12 (Vehicles). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Richard Gebhardt's most well-known trademarks?
Richard Gebhardt's registered trademark portfolio includes well-known marks such as TURCHAI, TURMACHA, TURMOCHA, and TURPUMPKIN. These are among 4 currently registered trademarks in the portfolio.
What is Richard Gebhardt's trademark registration success rate?
Richard Gebhardt has a 27% trademark registration rate, with 4 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.